Literature DB >> 22793939

Genes and chronic obstructive pulmonary disease.

Marilyn G Foreman1, Michael Campos, Juan C Celedón.   

Abstract

Although much remains to be done, recent advances and the advent of new methodologies are promising and should yield increased understanding of the genetic and epigenetic mechanisms influencing the pathogenesis of COPD, both related and unrelated to severe AAT deficiency. Such understanding should ultimately be translated into novel approaches to prevent, diagnose, and treat COPD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22793939      PMCID： PMC3399759          DOI： 10.1016/j.mcna.2012.02.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  81 in total

1.  Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency.

Authors:  A Novoradovsky; M L Brantly; M A Waclawiw; P P Chaudhary; H Ihara; L Qi; N T Eissa; P M Barnes; K M Gabriele; M E Ehrmantraut; P Rogliani; J Moss
Journal:  Am J Respir Cell Mol Biol       Date:  1999-03       Impact factor: 6.914

2.  Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells.

Authors:  J Cichy; J Potempa; J Travis
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

Review 3.  Lung volume reduction surgery for patients with alpha-1 antitrypsin deficiency emphysema.

Authors:  James M Donahue; Stephen D Cassivi
Journal:  Thorac Surg Clin       Date:  2009-05       Impact factor: 1.750

4.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus.

Authors:  E K Silverman; M A Province; E J Campbell; J A Pierce; D C Rao
Journal:  Hum Hered       Date:  1990       Impact factor: 0.444

5.  alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis.

Authors:  Irina Petrache; Iwona Fijalkowska; Terry R Medler; Jarrett Skirball; Pedro Cruz; Lijie Zhen; Horia I Petrache; Terence R Flotte; Rubin M Tuder
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association.

Authors:  M J Tobin; P J Cook; D C Hutchison
Journal:  Br J Dis Chest       Date:  1983-01

7.  Heritability of lung function in severe alpha-1 antitrypsin deficiency.

Authors:  D L DeMeo; E J Campbell; M L Brantly; A F Barker; E Eden; N G McElvaney; S I Rennard; J M Stocks; J K Stoller; C Strange; G Turino; R A Sandhaus; E K Silverman
Journal:  Hum Hered       Date:  2008-10-17       Impact factor: 0.444

8.  Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.

Authors:  F J de Serres; I Blanco; E Fernández-Bustillo
Journal:  Clin Genet       Date:  2003-11       Impact factor: 4.438

9.  alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization.

Authors:  D A Lomas; P R Elliott; S K Sidhar; R C Foreman; J T Finch; D W Cox; J C Whisstock; R W Carrell
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

10.  Protective effects of alpha 1-antitrypsin on acute lung injury in rabbits induced by endotoxin.

Authors:  Zhijun Jie; Yingyun Cai; Wenlan Yang; Meiling Jin; Wei Zhu; Cifang Zhu
Journal:  Chin Med J (Engl)       Date:  2003-11       Impact factor: 2.628
View more
  11 in total

1.  Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database.

Authors:  Tyler McGrady; David M Mannino; Elisha Malanga; Byron M Thomashow; John Walsh; Robert A Sandhaus; James K Stoller
Journal:  Chronic Obstr Pulm Dis       Date:  2015-04-15

2.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

3.  The clinical and genetic features of COPD-asthma overlap syndrome.

Authors:  Megan Hardin; Michael Cho; Merry-Lynn McDonald; Terri Beaty; Joe Ramsdell; Surya Bhatt; Edwin J R van Beek; Barry J Make; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  Eur Respir J       Date:  2014-05-29       Impact factor: 16.671

Review 4.  Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis.

Authors:  Yangxue Li; Yang Lu; Zhuo Zhao; Junnan Wang; Jianxin Li; Weiming Wang; Shumei Li; Lei Song
Journal:  J Res Med Sci       Date:  2016-03-15       Impact factor: 1.852

5.  Genetic Variants in the Hedgehog Interacting Protein Gene Are Associated with the FEV1/FVC Ratio in Southern Han Chinese Subjects with Chronic Obstructive Pulmonary Disease.

Authors:  Zili Zhang; Jian Wang; Zeguang Zheng; Xindong Chen; Xiansheng Zeng; Yi Zhang; Defu Li; Jiaze Shu; Kai Yang; Ning Lai; Lian Dong; Wenju Lu
Journal:  Biomed Res Int       Date:  2017-08-27       Impact factor: 3.411

Review 6.  Tocotrienols: Dietary Supplements for Chronic Obstructive Pulmonary Disease.

Authors:  Xiangming Ji; Hongwei Yao; Maureen Meister; Douglas S Gardenhire; Huanbiao Mo
Journal:  Antioxidants (Basel)       Date:  2021-05-31

7.  Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis.

Authors:  Hongbin Zhou; Yinfang Wu; Yan Jin; Jiesen Zhou; Chao Zhang; Luanqing Che; Jiyong Jing; Zhihua Chen; Wen Li; Huahao Shen
Journal:  Sci Rep       Date:  2013-10-02       Impact factor: 4.379

8.  A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.

Authors:  M Hardin; M H Cho; M-L McDonald; E Wan; D A Lomas; H O Coxson; W MacNee; J Vestbo; J C Yates; A Agusti; P M A Calverley; B Celli; C Crim; S Rennard; E Wouters; P Bakke; S P Bhatt; V Kim; J Ramsdell; E A Regan; B J Make; J E Hokanson; J D Crapo; T H Beaty; C P Hersh
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

9.  Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.

Authors:  Michael A Campos; Michael C Runken; Angela M Davis; Michael P Johnson; Glenda A Stone; Ami R Buikema
Journal:  Adv Ther       Date:  2018-04-03       Impact factor: 3.845

10.  Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease.

Authors:  Farzian Aminuddin; Tillie-Louise Hackett; Dorota Stefanowicz; Aabida Saferali; Peter D Paré; Amund Gulsvik; Per Bakke; Michael H Cho; Augusto Litonjua; David A Lomas; Wayne H Anderson; Terri H Beaty; Edwin K Silverman; Andrew J Sandford
Journal:  BMC Pulm Med       Date:  2013-11-06       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.